Definity RT (Perflutren Lipid Microspheres) Patent Expiration, LOE Window & CMS Spending

Definity RT (Perflutren Lipid Microspheres) by Lantheus Medical Imaging: FDA Orange Book core substance LOE 2035-12-28 (last listed 2037-05-04), 0 AB generics, $62K 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorLantheus Medical Imaging
FDA Application & PathwayN021064 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE Date2035-12-28
Last Listed Patent or Exclusivity Date2037-05-04
Orange Book Patents (*PED Extensions)11 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$62K
2024 Medicare Part D Spend$0
2024 Medicaid Spend$62K
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel